Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product
Status:
Completed
Trial end date:
2019-11-25
Target enrollment:
Participant gender:
Summary
This Pilot study will investigate the bioavailability in fasting women of 2 tablet
formulations containing Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg.
The Pilot study will be performed at a single site with 10 subjects. Participants will take 2
tablets of the test product and reference product in 2 periods and 2 sequences (either test
after reference or reference after test). There will be a washout of at least 14 days between
each study period.